Monday, March 8, 2021 Daily Archives

Precigen: ‘Electroporation a game changer for cell therapy production’

by

Precigen says the electroporation device used to make its UltraCAR-T therapies is a game changer for cell therapy production. The US biotech spoke about the technology – the UltraPorator – during its recent Q4 call, citing US FDA approval for its use in the production of investigational UltraCAR-T therapies as a highlight of 2020. According to CEO Helen Sabzevari, “UltraPorator is a potential game-changer for manufacturing of personalized UltraCAR-T therapies as it significantly reduces processing time and contamination risk. “While…

March 8, 2021

Fujifilm says Denmark expansion meets continued CDMO demand

by

Fujifilm Diosynth Biotechnologies says the continual growth of the biopharma CDMO market means its Danish site will help meet industry demands as it begins its $928 million cell culture expansion project. In June 2020, the firm announced plans to invest $928 million to double capacity at the Danish site it acquired from Biogen in 2019. The capacity was 90,000 L and the expansion (which started last week) will boast another six large-scale stainless-steel tanks, giving a total capacity of 240,000…

March 8, 2021